MY ACCOUNT | NEWSLETTER |

Swine Antibiotic Resistance


Antimicrobial resistance (AMR) occurs when pathogens, such as bacteria, viruses, fungi, and parasites, adapt and become resistant to antimicrobial treatments. Bacterial resistance is currently the most problematic issue. The United States swine industry uses roughly the same amount of medically important antibiotics as in human medicine, resulting in increased antibiotic resistance to bacteria affecting pigs. This not only affects swine production, but also impacts human health, because resistant organisms are transferred through the food chain.

How does antibiotic resistance develop?

Bacteria can genetically mutate or attain a gene from an already resistant bacterium to develop resistance. These resistant bacteria pass on this ability to subsequent generations. Resistant bacteria can reproduce rapidly, since they have a selective advantage and face no competition from non-resistant bacteria. Antibiotic resistance can be accomplished in several ways:

  • The bacteria can modify their metabolic pathways to avoid a drug’s effects.
  • The bacteria can manufacture enzymes that break down the antimicrobial medication. An enzyme family called the Extended-Spectrum beta-Lactamases (ESBLs) inactivate penicillins and cephalosporins, and are most commonly produced by Escherichia coli and Klebsiella pathogens.
  • The bacteria can modify the antibiotic binding site, preventing the drug from attacking the bacteria. This is the mechanism behind methicillin-resistant Staphylococcus aureus (MRSA) resistance. 
  • The bacteria can pump out the antibiotic, decreasing the drug’s efficacy. Tetracycline resistance is accomplished in this manner.

Using antimicrobial drugs in any treatment protocol can lead to resistance, but overusing antibiotics and not following dosing instructions has led to increased resistance. Stopping an antibiotic course too early, or using antibiotics at a subtherapeutic dose, also can promote resistance. Currently, antimicrobial resistance is occurring faster than new medicines are being produced, which is a concerning worldwide challenge as combating infection becomes more difficult.

How are antibiotics used in pigs?

In 2017, the Food and Drug Administration (FDA) banned using antibiotics to enhance growth rate and production performance in animals. Drugs once available over the counter can now be obtained only with a veterinary prescription. However, antibiotics are still used to accomplish two main goals in swine production.

  • Prophylactic or metaphylactic treatment — Prophylactic treatment involves medicating a single animal to prevent illness rather than fight infection. Metaphylactic treatment is treating an entire herd or flock to prevent, rather than treat, infection. Antibiotics are administered through the pig’s feed to save time and money on large-scale commercial pig farms. 
  • Therapeutic treatment — Pigs affected by an infection are dosed individually, orally or by injection, using a wide range of antibiotics, including medically important antibiotics used in human medicine.

Concentrating more pigs on fewer farms has led to antibiotic misuse. Housing numerous pigs in close quarters increases their infection risk, so producers use metaphylactic treatments to attempt to mitigate these risks. However, viral infections, such as swine flu and porcine respiratory and reproductive syndrome, have recently become more prevalent. These viruses typically result in secondary bacterial infections, questioning the claim that metaphylactic treatment reduces disease occurrence.

What is the risk to human health?

Antibiotics abuse causes environmental pollution by contaminating manure, soil, and water. This practice also poses a risk to human health through food-borne antibiotic residues and selection for AMR. AMR can spread directly by contacting an antibiotic-resistant bacteria from swine, or indirectly by contacting resistant organisms that have been spread through food, water, and animal waste used to fertilize soil. Many antibiotic classes are used in swine production, as well as human medicine. Spreading AMR from overuse in the swine industry will result in fewer therapeutic options to treat human diseases, which could result in prolonged illness, disability, or death.


Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

One Committed and Caring NC State Veterinary Student, So Many Choices

Like0
Dislike0

Dentalis Earns 5 VOHC® Seals, Positioning for Global Expansion in Animal Health

Like0
Dislike0

Advancing the 3Rs: innovation, implementation, ethics and society

Like0
Dislike0

Automated Knowledge-Based Radiation Treatment Planning in Canine and Feline Nasal Tumors

Like0
Dislike0

Does Lung Function Imaging Modality Have a Dosimetric Impact On Functional Avoidance Treatment Planning: Assessment Using Prospective Clinical Trial Data

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2025 - All Rights Reserved
ISSN 2768-198X

Top